CTFA challenges FDA analysis of consumer AHA adverse events -- CIR meeting.

CTFA DISPUTES FDA ANALYSIS OF CONSUMER AHA ADVERSE REACTION REPORTS at the March 5 meeting of the Cosmetic Ingredient Review Expert Panel in Washington, D.C. At the meeting, non-voting industry liaison Gerald McEwen, VP-science at the Cosmetic, Toiletry, and Fragrance Association, questioned the FDA statistic that for every cosmetic adverse reaction reported by a consumer to FDA, 50-100 are reported to manufacturers. "FDA has frequently over the years known things that I've been unable to find any validation for...this is probably one of those," McEwen asserted. "I submit the data does not support that," he concluded